Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [21] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    T. Dong-Si
    J. Weber
    Y. B. Liu
    C. Buhmann
    H. Bauer
    C. Bendl
    P. Schnitzler
    C. Grond-Ginsbach
    A. J. Grau
    Journal of Neurology, 2004, 251 : 542 - 547
  • [22] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [23] Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Lamers, KJB
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) : 446 - 451
  • [24] Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
    Herman, Stephanie
    Akerfeldt, Torbjorn
    Spjuth, Ola
    Burman, Joachim
    Kultima, Kim
    CELLS, 2019, 8 (02)
  • [25] Secretory Phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Siroos, Bahaadin
    Balood, Mohammad
    Zahednasab, Hamid
    Mesbah-Namin, Seyed Alireza
    Pourgholy, Fatemeh
    Harirchian, Mohammad Hossein
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 125 - 127
  • [26] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Dong-Si, T
    Weber, J
    Liu, YB
    Buhmann, C
    Bauer, H
    Bendl, C
    Schnitzler, P
    Grond-Ginsbach, C
    Grau, AJ
    JOURNAL OF NEUROLOGY, 2004, 251 (05) : 542 - 547
  • [27] Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis
    Hakansson, Irene
    Ernerudh, Jan
    Vrethem, Magnus
    Dahle, Charlotte
    Ekdahl, Kristina N.
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 340
  • [28] Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
    Arici Duz, Ozge
    Saatci, Ozlem
    Karakulak, Ece Zeynep
    Birday, Erkingul
    Hanoglu, Lutfu
    EUROPEAN NEUROLOGY, 2021, 84 (03) : 175 - 182
  • [29] Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis
    Orefice, N. S.
    Carotenuto, A.
    Mangone, G.
    Bues, B.
    Rehm, R.
    Cerillo, I.
    Sacca, F.
    Calignano, A.
    Orefice, G.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 159 : 1 - 7
  • [30] Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis
    Strijbis, Eva M.
    Coerver, Eline
    Mostert, Jop
    van Kempen, Zoe L. E.
    Killestein, Joep
    Comtois, Jacynthe
    Repovic, Pavle
    Bowen, James D.
    Cutter, Gary
    Koch, Marcus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (10) : 792 - 799